| Basics |
|
Niagen Bioscience, Inc
|
| IPO Date: |
June 25, 2007 |
| Sector: |
Healthcare |
| Industry: |
Biotechnology |
| Market Cap: |
$598.94M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.27 | 2.85%
|
| Avg Daily Range (30 D): |
$0.23 | 2.68%
|
| Avg Daily Range (90 D): |
$0.28 | 2.66%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.87M |
| Avg Daily Volume (30 D): |
.99M |
| Avg Daily Volume (90 D): |
.94M |
| Trade Size |
| Avg Trade Size (Sh.): |
75 |
| Avg Trade Size (Sh.) (30 D): |
80 |
| Avg Trade Size (Sh.) (90 D): |
72 |
| Institutional Trades |
| Total Inst.Trades: |
142 |
| Avg Inst. Trade: |
$1.15M |
| Avg Inst. Trade (30 D): |
$1.1M |
| Avg Inst. Trade (90 D): |
$1.25M |
| Avg Inst. Trade Volume: |
.11M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.19M |
| Avg Closing Trade (30 D): |
$1.15M |
| Avg Closing Trade (90 D): |
$1.28M |
| Avg Closing Volume: |
118.04K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
N/A |
|
Basic EPS
|
$.05
|
$.07
|
|
|
Diluted EPS
|
$.04
|
$.06
|
|
|
Revenue
|
$ 31.12M
|
$ 30.48M
|
$
|
|
Gross Profit
|
$ 20.23M
|
$ 19.33M
|
$
|
|
Net Income / Loss
|
$ 3.61M
|
$ 5.06M
|
$
|
|
Operating Income / Loss
|
$ 3.19M
|
$ 4.77M
|
$
|
|
Cost of Revenue
|
$ 10.89M
|
$ 11.15M
|
$
|
|
Net Cash Flow
|
$ 4.86M
|
$ 10.96M
|
$
|
|
PE Ratio
|
185.75
|
|
|
| Splits |
|
Dec 07, 2006:
3.19:1
|
|
|
|
